toll-like receptor 7 agonist DSP-0509
Term · Oncology and biomedicine · MLC-T-ONC-017231
A synthetic, small molecule, toll-like receptor (TLR) 7 agonist, with potential immunostimulatory and antineoplastic activities. Upon intravenous administration, TLR7 agonist DSP-0509 activates TLR7, thereby inducing type I interferon secretion and activation of cytotoxic T-lymphocyte (CTL)-mediated anti-tumor immune responses, thereby reducing tumor cell growth. TLR7 is a member of the TLR family, which plays a fundamental role in pathogen recognition and activation of innate immunity.
| Identifier | MLC-T-ONC-017231 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | TLR7 agonist DSP-0509 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017231",
"term": "toll-like receptor 7 agonist DSP-0509",
"field": "Oncology and biomedicine",
"definition": "A synthetic, small molecule, toll-like receptor (TLR) 7 agonist, with potential immunostimulatory and antineoplastic activities. Upon intravenous administration, TLR7 agonist DSP-0509 activates TLR7, thereby inducing type I interferon secretion and activation of cytotoxic T-lymphocyte (CTL)-mediated anti-tumor immune responses, thereby reducing tumor cell growth. TLR7 is a member of the TLR family, which plays a fundamental role in pathogen recognition and activation of innate immunity.",
"synonyms": [
"TLR7 agonist DSP-0509"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/toll-like-receptor-7-agonist-dsp-0509/"
}
Record 16,474 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.